Skip to main content
SpringerLink
Log in

Scleroderma heart disease: An unusual cause of positive antimyosin cardiac imaging

  • Nuclear Cardiology Bullet
  • Published:
Journal of Nuclear Cardiology Aims and scope

Summary

111In-antimyosin scintigraphy offers a valuable noninvasive method for early detection of clinically silent cardiac involvement in patients with systemic sclerosis, even in the absence of left ventricular dysfunction. In these patients with positive antimyosin study results, intense pharmacologic treatment with vasodilators may be warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976;53:483–90.

    PubMed  CAS  Google Scholar 

  2. Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papazoglou S, Papamichael C, et al. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis. Clin Exp Rheumatol 1998;16:135–40.

    PubMed  CAS  Google Scholar 

  3. Khaw BA, Narula J. Antibody imaging in the evaluation of cardiovascular diseases. J Nucl Cardiol 1994;1:457–76.

    Article  PubMed  CAS  Google Scholar 

  4. Sarda L, Georges C, Assayag P, Lebtahi R, Faraggi M, Palazzo E, et al. Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis. J Nucl Med 1997;38:1759–61.

    PubMed  CAS  Google Scholar 

  5. Duboc D, Kahan A, Maziere B, Loch C, Crouzel C, Menkes CJ, et al. The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study. Arthritis Rheum 1991;34:198–203.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Therapeutics, Athens University, 86 Alkionis St, P. Faliron 175 62, Athens, Greece

    John Lekakis, Myron Mavrikakis & Stamatios Stamatelopoulos

  2. Department of Nuclear Medicine, Alexandra Hospital, Athens, Greece

    Vassilios Prassopoulos, Sofia Gerali, Nicos Sifakis & Panos Kostamis

Authors
  1. John Lekakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Myron Mavrikakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vassilios Prassopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sofia Gerali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicos Sifakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Panos Kostamis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stamatios Stamatelopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Lekakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lekakis, J., Mavrikakis, M., Prassopoulos, V. et al. Scleroderma heart disease: An unusual cause of positive antimyosin cardiac imaging. J Nucl Cardiol 6, 91–92 (1999). https://doi.org/10.1016/S1071-3581(99)90069-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(99)90069-7

Keywords

Search

Navigation